Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 7, 2010; 16(41): 5225-5232
Published online Nov 7, 2010. doi: 10.3748/wjg.v16.i41.5225
Published online Nov 7, 2010. doi: 10.3748/wjg.v16.i41.5225
Table 3 Estimates of liver fibrosis using transient elastography in the study population n (%)
| LS | Metavir | HIV (n = 71) | HCV (n = 53) | HIV/HCV (n = 57) | |
| < 7.1 | F0-F1 | 56 (78.8) | 23 (43.4) | 19 (33.3) | |
| 7.1-9.4 | F2 | 11 (15.4) | 15 (28.3) | 9 (15.8) | |
| 9.5-12.4 | F3 | 1 (1.4) | 4 (7.5) | 9 (15.8) | |
| ≥ 12.5 | F4 | 3 (4.2) | 11 (20.7) | 20 (35.1) | χ2MH = 4, P < 0.04 |
| ≥ F3 | 4 (5.6) | 15 (28.3) | 29 (50.9) | χ2 = 5, P < 0.03 |
- Citation: Li Vecchi V, Soresi M, Colomba C, Mazzola G, Colletti P, Mineo M, Di Carlo P, La Spada E, Vizzini G, Montalto G. Transient elastography: A non-invasive tool for assessing liver fibrosis in HIV/HCV patients. World J Gastroenterol 2010; 16(41): 5225-5232
- URL: https://www.wjgnet.com/1007-9327/full/v16/i41/5225.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i41.5225